Is APOE ε4 associated with cognitive performance in early MS?
Sinah EngelChristiane GraetzAnke SalmenMuthuraman MuthuramanGerrit ToengesBjörn AmbrosiusAntonios BayasAchim BertheleChristoph HeesenLuisa KlotzTania KümpfelRalf A LinkerSven G MeuthFriedemann PaulMartin StangelBjörn TackenbergFlorian Then BerghHayrettin TumaniFrank WeberBrigitte WildemannUwe K ZettlGisela AntonyStefan BittnerSergiu GroppaBernhard HemmerHeinz WiendlRalf GoldFrauke ZippChristina M LillFelix Luessinull nullPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
Along with parameters of a higher disease burden, APOE ε4 homozygosity was identified as a potential predictor of cognitive performance in this large cohort of patients with CIS and early RRMS.